Therapeutic Potential of Celosia Argentea In the Management of Urolithiasis: A Comprehensive Phytochemical and Pharmacological Review

Urolithiasis, commonly known as kidney stones, is a significant global health concern affecting millions of individuals. It is characterized by the formation of mineral deposits within the urinary tract, often leading to severe pain, urinary obstruction, and recurrent episodes requiring medical intervention. The rising incidence of kidney stones has been linked to dietary habits, dehydration, metabolic disorders, and genetic predisposition. Despite advancements in surgical and pharmacological treatments, the high recurrence rate necessitates the exploration of alternative therapeutic options, including herbal remedies. Celosia argentea, a widely used medicinal plant in traditional medicine, has shown promising potential in urolithiasis management. Rich in bioactive compounds such as flavonoids, saponins, alkaloids, and tannins, C. argentea exhibits diuretic, antioxidant, anti-inflammatory, and nephroprotective properties that contribute to its antilithiatic effects. This review aims to explore the phytochemical constituents, pharmacological activities, and mechanisms by which C. argentea helps prevent or treat kidney stones. Key findings from various in vitro and in vivo studies suggest that C. argentea reduces urinary stone formation by inhibiting calcium oxalate crystallization, promoting urine output, and protecting renal tissues from oxidative stress-induced damage. However, despite these promising results, further clinical studies are needed to validate its efficacy, optimize dosage, and establish standardized formulations. Future research should focus on elucidating the molecular mechanisms underlying its nephroprotective effects and exploring its potential in combination therapies. Celosia argentea presents a natural and cost-effective alternative for kidney stone prevention and treatment, warranting further investigation for integration into modern urolithiasis management.